المؤلفون: Prerna Malaney, Aitken Mjl, Shelley M. Herbrich, Huaxian Ma, Rodrigo Jacamo, C. E. Bueso-Ramos, Lauren E. Chan, Sean M. Post, Todd M. Link, Steve Kornblau, Rashmi Kanagal-Shamanna, Ruizhi Duan, Xiang Zhang

مصطلحات موضوعية: Myeloid, Alternative splicing, Myeloid leukemia, RNA-binding protein, Biology, medicine.disease, chemistry.chemical_compound, Leukemia, medicine.anatomical_structure, RUNX1, chemistry, hemic and lymphatic diseases, RNA splicing, medicine, Cancer research, Heterogeneous-Nuclear Ribonucleoprotein K

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::e43341cbdf775bf8da379e2d41558bc0
https://doi.org/10.1101/2021.02.05.429385

المؤلفون: Aitken MJL; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA., Malaney P; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Biochemistry and Cell Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA; Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA., Zhang X; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Herbrich SM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA.; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chan L; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Benitez O; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rodriguez AG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ma H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jacamo R; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Duan R; School of Health Professions, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Baylor College of Medicine, Houston, TX, USA., Link TM; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kornblau SM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bueso-Ramos CE; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Post SM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

المصدر: NAR cancer [NAR Cancer] 2022 Dec 09; Vol. 4 (4), pp. zcac039. Date of Electronic Publication: 2022 Dec 09 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101769553 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-8674 (Electronic) Linking ISSN: 26328674 NLM ISO Abbreviation: NAR Cancer Subsets: PubMed not MEDLINE

المؤلفون: Post SM; Department of Leukemia. SPost@mdanderson.org., Ma H; Department of Leukemia; Section of Molecular Hematology, The University of Texas MD Anderson Cancer Center, Houston., Malaney P; Department of Leukemia., Zhang X; Department of Leukemia., Aitken MJL; Department of Leukemia., Mak PY; Department of Leukemia; Section of Molecular Hematology, The University of Texas MD Anderson Cancer Center, Houston., Ruvolo VR; Department of Leukemia; Section of Molecular Hematology, The University of Texas MD Anderson Cancer Center, Houston., Yasuhiro T; Ono Pharmaceutical Co. Ltd., Research Center of Oncology, Osaka., Kozaki R; Ono Pharmaceutical Co. Ltd., Research Center of Oncology, Osaka., Chan LE; Department of Leukemia., Ostermann LB; Department of Leukemia; Section of Molecular Hematology, The University of Texas MD Anderson Cancer Center, Houston., Konopleva M; Department of Leukemia., Carter BZ; Department of Leukemia; Section of Molecular Hematology, The University of Texas MD Anderson Cancer Center, Houston., DiNardo C; Department of Leukemia., Andreeff MD; Department of Leukemia; Section of Molecular Hematology, The University of Texas MD Anderson Cancer Center, Houston., Khoury JD; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston. JKhoury@mdanderson.org., Ruvolo PP; Department of Leukemia; Section of Molecular Hematology, The University of Texas MD Anderson Cancer Center, Houston. pruvolo@mdanderson.org.

المصدر: Haematologica [Haematologica] 2022 Jun 01; Vol. 107 (6), pp. 1311-1322. Date of Electronic Publication: 2022 Jun 01.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

مواضيع طبية MeSH: Drug Resistance, Neoplasm* , Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/genetics , Protein Kinase Inhibitors*/pharmacology , c-Mer Tyrosine Kinase*/antagonists & inhibitors, Animals ; Apoptosis ; Bridged Bicyclo Compounds, Heterocyclic/pharmacology ; Cell Line, Tumor ; Extracellular Signal-Regulated MAP Kinases/metabolism ; Humans ; Mice ; Myeloid Cell Leukemia Sequence 1 Protein/metabolism ; Proteomics ; Sulfonamides/pharmacology ; fms-Like Tyrosine Kinase 3/genetics

المؤلفون: Kannan S; Department of Pediatrics Research, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.; Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA., Irwin ME; Department of Pediatrics Research, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA., Herbrich SM; Department of Pediatrics Research, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.; University of Texas MD Anderson UT Health Graduate School of Biomedical Sciences, Houston, TX 77004, USA., Cheng T; Department of Pediatrics Research, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA., Patterson LL; Department of Pediatrics Research, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA., Aitken MJL; Department of Pediatrics Research, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.; University of Texas MD Anderson UT Health Graduate School of Biomedical Sciences, Houston, TX 77004, USA., Bhalla K; Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA., You MJ; Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA., Konopleva M; Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA., Zweidler-McKay PA; Department of Pediatrics Research, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.; University of Texas MD Anderson UT Health Graduate School of Biomedical Sciences, Houston, TX 77004, USA.; ImmunoGen, Waltham, MA 02451, USA., Chandra J; Department of Pediatrics Research, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.; University of Texas MD Anderson UT Health Graduate School of Biomedical Sciences, Houston, TX 77004, USA.; Epigenetics and Molecular Carcinogenesis, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.

المصدر: Antioxidants (Basel, Switzerland) [Antioxidants (Basel)] 2022 Apr 05; Vol. 11 (4). Date of Electronic Publication: 2022 Apr 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101668981 Publication Model: Electronic Cited Medium: Print ISSN: 2076-3921 (Print) Linking ISSN: 20763921 NLM ISO Abbreviation: Antioxidants (Basel) Subsets: PubMed not MEDLINE

المؤلفون: Aitken MJL; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; McGovern Medical School, UT Health Science Center-Houston, Houston, TX, USA.; Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Patel KP; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. NShort@mdanderson.org.

المصدر: Journal of hematology & oncology [J Hematol Oncol] 2021 Sep 03; Vol. 14 (1), pp. 137. Date of Electronic Publication: 2021 Sep 03.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute/*diagnosis , Neoplasm, Residual/*diagnosis, Animals ; Disease Management ; Flow Cytometry ; Hematopoietic Stem Cell Transplantation ; High-Throughput Nucleotide Sequencing ; Humans ; Immunotherapy ; Karyotyping ; Leukemia, Myeloid, Acute/genetics ; Leukemia, Myeloid, Acute/therapy ; Neoplasm, Residual/genetics ; Neoplasm, Residual/therapy ; Prognosis

المؤلفون: Herbrich S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Baran N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Cai T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Weng C; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Aitken MJL; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Post SM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Henderson J; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Shi C; Oncology Research for Biologics and Immunotherapy Translation (ORBIT) platform, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Richard-Carpentier G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Sauvageau G; University of Montreal Institute for Research in Immunology and Cancer, Montreal, Quebec, Canada., Baggerly K; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Al-Atrash G; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Davis RE; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Zha D; Oncology Research for Biologics and Immunotherapy Translation (ORBIT) platform, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA mkonople@mdanderson.org.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Jul; Vol. 9 (7).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antigens, CD/*metabolism , Immune Evasion/*genetics , Leukemia, Myeloid, Acute/*genetics, Animals ; Humans ; Mice ; Mice, Inbred NOD

المؤلفون: Malaney P; Department of Leukemia, MD Anderson Cancer Center, Houston, TX, United States., Velasco-Estevez M; H12O-CNIO Haematological Malignancies Clinical Research Unit, CNIO, Madrid, Spain., Aguilar-Garrido P; H12O-CNIO Haematological Malignancies Clinical Research Unit, CNIO, Madrid, Spain., Aitken MJL; Department of Leukemia, MD Anderson Cancer Center, Houston, TX, United States., Chan LE; Department of Leukemia, MD Anderson Cancer Center, Houston, TX, United States., Zhang X; Department of Leukemia, MD Anderson Cancer Center, Houston, TX, United States., Post SM; Department of Leukemia, MD Anderson Cancer Center, Houston, TX, United States., Gallardo M; H12O-CNIO Haematological Malignancies Clinical Research Unit, CNIO, Madrid, Spain.

المصدر: Frontiers in immunology [Front Immunol] 2021 Apr 12; Vol. 12, pp. 634584. Date of Electronic Publication: 2021 Apr 12 (Print Publication: 2021).

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: B-Lymphocytes/*metabolism , Cell Transformation, Neoplastic/*metabolism , Heterogeneous-Nuclear Ribonucleoprotein K/*metabolism , Lymphoma, B-Cell/*metabolism, Animals ; Animals, Genetically Modified ; B-Lymphocytes/immunology ; B-Lymphocytes/pathology ; Cell Transformation, Neoplastic/genetics ; Cell Transformation, Neoplastic/immunology ; Cell Transformation, Neoplastic/pathology ; Disease Models, Animal ; Gene Expression Regulation, Neoplastic ; Genetic Predisposition to Disease ; Heterogeneous-Nuclear Ribonucleoprotein K/genetics ; Lymphoma, B-Cell/genetics ; Lymphoma, B-Cell/immunology ; Lymphoma, B-Cell/pathology ; Phenotype ; Proto-Oncogene Proteins c-myc/genetics ; Proto-Oncogene Proteins c-myc/metabolism ; Up-Regulation

المؤلفون: Aitken MJL; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; McGovern Medical School, Houston, Texas, USA., Benton CB; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Rocky Mountain Cancer Center, Denver, Colorado, USA., Issa GC; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Yilmaz M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA, nshort@mdanderson.org.

المصدر: Acta haematologica [Acta Haematol] 2021; Vol. 144 (5), pp. 585-590. Date of Electronic Publication: 2021 Mar 18.

نوع المنشور: Case Reports

بيانات الدورية: Publisher: Karger Country of Publication: Switzerland NLM ID: 0141053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1421-9662 (Electronic) Linking ISSN: 00015792 NLM ISO Abbreviation: Acta Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Family* , Translocation, Genetic*, Chromosomes, Human, Pair 22/*genetics , Chromosomes, Human, Pair 9/*genetics , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*genetics , Neoplastic Syndromes, Hereditary/*genetics, Adult ; Aged ; Female ; Humans

المؤلفون: Aitken MJL; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; The University of Texas MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences, Houston, Texas, USA., Benton CB; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Wang F; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Zhang J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Herbrich SM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; The University of Texas MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences, Houston, Texas, USA., Takahashi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Bueso-Ramos CE; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

المصدر: American journal of hematology [Am J Hematol] 2020 Sep; Vol. 95 (9), pp. 1117-1120. Date of Electronic Publication: 2020 May 08.

نوع المنشور: Case Reports; Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Precursor Cell Lymphoblastic Leukemia-Lymphoma*/blood , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/pathology , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/therapy, Adult ; Child ; Female ; Follow-Up Studies ; Humans

المؤلفون: Gallardo M; Department of Leukemia.; H12O-CNIO Haematological Malignancies Clinical Research Unit, Clinical Research Programme, CNIO, Madrid, Spain., Malaney P; Department of Leukemia., Aitken MJL; Department of Leukemia.; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences., Zhang X; Department of Leukemia., Link TM; Department of Genomic Medicine., Shah V; Department of Epigenetics and Molecular Carcinogenesis., Alybayev S; Department of Molecular Oncology., Wu MH; Department of Leukemia., Pageon LR; Department of Veterinary Medicine and Surgery., Ma H; Department of Leukemia., Jacamo R; Department of Leukemia., Yu L; Department of Hematopathology., Xu-Monette ZY; Department of Hematopathology., Steinman H; Department of Leukemia., Lee HJ; Department of Lymphoma and Myeloma The University of Texas, MD Anderson Cancer Center, Houston, TX., Sarbassov D; Department of Molecular Oncology., Rapado I; Department of Hematology, Hospital Universitario Madrid, Spain., Barton MC; Department of Epigenetics and Molecular Carcinogenesis., Martinez-Lopez J; Department of Hematology, Hospital Universitario Madrid, Spain., Bueso-Ramos C; Department of Hematopathology., Young KH; Department of Hematopathology., Post SM; Department of Leukemia.

المصدر: Journal of the National Cancer Institute [J Natl Cancer Inst] 2020 Jan 01; Vol. 112 (1), pp. 95-106.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE

مواضيع طبية MeSH: Disease Susceptibility*, Heterogeneous-Nuclear Ribonucleoprotein K/*genetics , Heterogeneous-Nuclear Ribonucleoprotein K/*metabolism , Lymphoma, B-Cell/*etiology , Lymphoma, B-Cell/*metabolism, Adult ; Aged ; Animals ; Antineoplastic Agents/pharmacology ; Cell Line, Tumor ; Disease Models, Animal ; Female ; Gene Expression ; Gene Expression Regulation, Neoplastic ; Heterogeneous-Nuclear Ribonucleoprotein K/chemistry ; Humans ; Lymphoma, B-Cell/mortality ; Lymphoma, B-Cell/pathology ; Male ; Mice ; Mice, Transgenic ; Middle Aged ; Neoplasm Staging ; Phenotype ; Protein Binding ; Protein Interaction Domains and Motifs/drug effects ; RNA-Binding Proteins/genetics ; RNA-Binding Proteins/metabolism